Prowess files patent infringement lawsuit against RaySearch in Baltimore court

NewsGuard 100/100 Score

As previously announced, RaySearch Laboratories AB (publ.) (STO:RAYB) has been contacted by a US company named Prowess, which claims that RaySearch has infringed on a US patent in respect of which Prowess has a license.

The patent concerns direct optimization of machine parameters in radiation treatment planning and was issued in 2007 by the US patent authority USPTO. Prowess has said that it holds an exclusive license to this patent which is owned by the University of Maryland. RaySearch has been involved in discussions with Prowess where RaySearch has stated its position that there is no infringement and in addition, that the patent could be invalidated since there is prior art in older publications describing the same concept.

These discussions have unfortunately been fruitless and Prowess has now filed a Complaint against RaySearch for patent infringement in a court in Baltimore, Maryland. This means that a legal process will commence that is likely to last for a long period of time. At this point it is, however, difficult to estimate how long it will last and how large RaySearch's costs will be.

"This concerns a method that we had independently developed and implemented at the Karolinska Institute already in the 90's. In addition, both we and others had published articles about the method before this patent application was filed. We do believe that we have a strong case and therefore consider our chances of winning this dispute to be good," says Johan Löf, CEO of RaySearch.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.